Cart
sales@molnova.com
PG-116800
CAS No. 291533-11-4
PG-116800( —— )
Catalog No. M34377 CAS No. 291533-11-4
PG-116800 (PG-530742) is a matrix metalloproteinase (MMP) inhibitor. PG-116800 can be used in studies about the treatment of osteoarthritis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 456 | In Stock |
|
| 10MG | 653 | In Stock |
|
| 25MG | 1026 | In Stock |
|
| 50MG | 1376 | In Stock |
|
| 100MG | 1851 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3646 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePG-116800
-
NoteResearch use only, not for human use.
-
Brief DescriptionPG-116800 (PG-530742) is a matrix metalloproteinase (MMP) inhibitor. PG-116800 can be used in studies about the treatment of osteoarthritis.
-
DescriptionPG 116800 (PG 530742) is an orally avtive MMP inhibitor. PG 116800 has high affinity for MMP-2, -3, -8, -9, -13, and -14, while having substantially lower affinity for MMP-1 and -7. PG 116800 can be used for knee osteoarthritis research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetMMP
-
RecptorMMP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number291533-11-4
-
Formula Weight501.55
-
Molecular FormulaC24H27N3O7S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(NC(CC#CCN1CCOCC1)C(O)=O)(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(OC)C=C3)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Piotr Krzeski, et al. Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. Arthritis Res Ther. 2007;9(5):R109. ?
molnova catalog
related products
-
Prinomastat
Prinomastat (AG3340) is a potent, selective MMP inhibitor with pM affinities for inhibiting gelatinases (MMP-2 and -9, Ki=50-150 pM).
-
TAPI1
TAPI-1, an ADAM17/TACE inhibitor, inhibits shedding of cytokine receptors.
-
Calycosin-7-O-beta-D...
Calycosin 7-O-β-D-glucoside has antimicrobial activity. Calycosin 7-O-β-D-glucoside is anticipated to be a promising anti-HIV agent.
